Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease
Authors not listed
Charite University, Berlin, Germany · 2021
Abstract
Chronic kidney disease (CKD) is associated with an increased cardiovascular mortality. In particular children with early-onset CKD have a lifelong increased risk to suffer from cardiovascular disease (CVD). Therefore, children with CKD deserve our attention. The immune system in children with CKD is disturbed, exhibiting pro-inflammatory features. Therefore, we aim to learn more about the characteristics of the immune system in early-onset CKD. In this project PBMC of pediatric CKD patients and age-matched healthy controls will be analysed and compared using CITE-Seq as a multimodal scRNAseq phenotyping method. All patients will be clinically characterized to integrate cardiovascular and immunological data.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-05-29 MST
Cite this
APA
Anonymous. (2021). Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease. <em>Charite University, Berlin, Germany</em>. https://clinicaltrials.gov/study/NCT04976010
Vancouver
Anonymous. Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease. Charite University, Berlin, Germany. 2021.
BibTeX
@misc{anon2021Single,
title = {Single Cell Leukocyte Landscapes and Cardiovascular Risk in Children With Chronic Kidney Disease},
author = {Anonymous},
journal = {Charite University, Berlin, Germany},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cachexia Sarcopenia and Muscle 2022
Open access · CC-BY
The impact of senescence on muscle wasting in chronic kidney disease
Kidney International Reports 2021
Open access · CC-BY
Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2
Frontiers in Immunology 2021
Open access · CC-BY
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation
International Journal of Molecular Sciences 2018
Open access · CC-BY
mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases
University Hospital, Clermont-Ferrand 2011
Open access · US-GOV
Evaluation of Metamemory in Patients With Schizophrenia
International Journal of Molecular Sciences 2020
Open access · CC-BY